Treasurer Of The State Of North Carolina Alnylam Pharmaceuticals, Inc. Transaction History

Treasurer Of The State Of North Carolina

  • $25.7 Billion
  • Q4 2024

A detailed history of Treasurer Of The State Of North Carolina transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Treasurer Of The State Of North Carolina holds 86,915 shares of ALNY stock, worth $23.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
86,915
Previous 84,605 2.73%
Holding current value
$23.5 Million
Previous $23.3 Million 12.11%
% of portfolio
0.08%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$232.27 - $300.43 $536,543 - $693,993
2,310 Added 2.73%
86,915 $20.5 Million
Q3 2024

Nov 14, 2024
BUY
$233.81 - $287.01 $1.18 Million - $1.45 Million
5,040 Added 6.33%
84,605 $23.3 Million
Q2 2024

Aug 14, 2024
SELL
$143.31 - $247.0 $1.12 Million - $1.93 Million
-7,822 Reduced 8.95%
79,565 $19.3 Million
Q1 2024

May 09, 2024
BUY
$146.51 - $198.2 $101,091 - $136,758
690 Added 0.8%
87,387 $13.1 Million
Q4 2023

Feb 12, 2024
BUY
$151.41 - $196.57 $112,043 - $145,461
740 Added 0.86%
86,697 $16.6 Million
Q3 2023

Nov 13, 2023
SELL
$170.77 - $211.65 $163,939 - $203,184
-960 Reduced 1.1%
85,957 $15.2 Million
Q2 2023

Aug 14, 2023
SELL
$185.01 - $212.05 $288,615 - $330,798
-1,560 Reduced 1.76%
86,917 $16.5 Million
Q1 2023

May 04, 2023
BUY
$182.66 - $235.53 $385,412 - $496,968
2,110 Added 2.44%
88,477 $17.7 Million
Q4 2022

Feb 09, 2023
BUY
$185.53 - $241.31 $348,796 - $453,662
1,880 Added 2.23%
86,367 $20.5 Million
Q3 2022

Nov 08, 2022
BUY
$138.54 - $232.0 $69,270 - $116,000
500 Added 0.6%
84,487 $16.9 Million
Q2 2022

Aug 02, 2022
BUY
$120.42 - $169.29 $774,059 - $1.09 Million
6,428 Added 8.29%
83,987 $12.3 Million
Q1 2022

May 10, 2022
BUY
$127.18 - $173.91 $225,744 - $308,690
1,775 Added 2.34%
77,559 $12.7 Million
Q4 2021

Feb 14, 2022
SELL
$159.56 - $209.29 $82,971 - $108,830
-520 Reduced 0.68%
75,784 $12.9 Million
Q3 2021

Nov 03, 2021
BUY
$169.75 - $207.73 $565,097 - $691,533
3,329 Added 4.56%
76,304 $14.4 Million
Q2 2021

Aug 13, 2021
BUY
$128.63 - $176.89 $129,916 - $178,658
1,010 Added 1.4%
72,975 $12.4 Million
Q1 2021

May 03, 2021
SELL
$126.83 - $175.69 $74,449 - $103,130
-587 Reduced 0.81%
71,965 $10.2 Million
Q4 2020

Feb 02, 2021
BUY
$122.97 - $147.0 $135,267 - $161,700
1,100 Added 1.54%
72,552 $9.43 Million
Q3 2020

Nov 04, 2020
BUY
$121.19 - $165.49 $515,057 - $703,332
4,250 Added 6.32%
71,452 $10.4 Million
Q2 2020

Aug 07, 2020
BUY
$104.21 - $156.44 $1.39 Million - $2.09 Million
13,385 Added 24.87%
67,202 $9.95 Million
Q1 2020

May 13, 2020
BUY
$93.12 - $133.99 $1.76 Million - $2.53 Million
18,910 Added 54.17%
53,817 $5.86 Million
Q4 2019

Feb 12, 2020
SELL
$74.51 - $124.23 $472,393 - $787,618
-6,340 Reduced 15.37%
34,907 $4.02 Million
Q3 2019

Nov 07, 2019
SELL
$70.9 - $87.82 $1.68 Million - $2.08 Million
-23,663 Reduced 36.46%
41,247 $3.32 Million
Q2 2019

Aug 23, 2019
SELL
$65.86 - $92.79 $43,796 - $61,705
-665 Reduced 1.01%
64,910 $4.71 Million
Q1 2019

Aug 07, 2019
BUY
$72.76 - $93.45 $109,867 - $141,109
1,510 Added 2.36%
65,575 $6.13 Million
Q4 2018

Aug 07, 2019
BUY
$62.67 - $88.33 $71,255 - $100,431
1,137 Added 1.81%
64,065 $4.67 Million
Q3 2018

Aug 07, 2019
BUY
$87.52 - $122.67 $3.66 Million - $5.13 Million
41,856 Added 198.63%
62,928 $5.51 Million
Q2 2018

Aug 07, 2019
BUY
$88.31 - $107.8 $1.04 Million - $1.27 Million
11,826 Added 127.9%
21,072 $2.08 Million
Q1 2018

Jul 24, 2019
BUY
$115.92 - $148.54 $1.07 Million - $1.37 Million
9,246 New
9,246 $1.1 Million

Others Institutions Holding ALNY

# of Institutions
671
Shares Held
108M
Call Options Held
839K
Put Options Held
771K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $33.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Treasurer Of The State Of North Carolina Portfolio

Follow Treasurer Of The State Of North Carolina and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

News

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email